246
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Relationship Between Adherence to Opioid Analgesics and Pain Beliefs Among Patients with Cancer Pain at Tertiary Care Hospitals in Malaysia

, , , ORCID Icon & ORCID Icon
Pages 1411-1419 | Published online: 12 Aug 2020

References

  • Ministry of Health Malaysia. Health facts 2016. Available from: http://www.moh.gov.my/moh/images/gallery/publications/KKM%20HEALTH%20FACTS%202016.pdf. Accessed July 28, 2018.
  • Ibrahim NA, Oludara MA. Socio-demographic factors and reasons associated with delay in breast cancer presentation: a study in Nigerian women. Breast. 2012;21(3):416–418. doi:10.1016/j.breast.2012.02.006
  • Ghazali SM, Othman Z, Cheong KC, et al. Non-Practice of breast self examination and marital status are associated with delayed presentation with breast cancer. Asian Pac J Cancer Prev. 2013;14(2):1141–1145. doi:10.7314/APJCP.2013.14.2.1141
  • Cheng ML, Ling DY, Nanu P, et al. Factors influencing late stage of breast cancer at presentation in a district hospital—Segamat Hospital, Johor. Med J Malaysia. 2015;70(3):148–152.
  • Mohd Mujar NM, Dahlui M, Emran NA, et al. Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia. PLoS One. 2017;12(4):e0176394. doi:10.1371/journal.pone.0176394
  • Raja Lexshimi RG, Oranye NO, Ho SE, et al. Complementary and alternative medicine use among cancer patients. Malaysian J Public Health Med. 2013;13(1):11–19.
  • Zulkipli AF, Islam T, Mohd Taib NA, et al. Use of complementary and alternative medicine among newly diagnosed breast cancer patients in Malaysia: an early report from the MyBCC study. Integr Cancer Ther. 2018;17(2):312–321. doi:10.1177/1534735417745248
  • Van Den Beuken-van Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ, et al. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51:1070–1090. doi:10.1016/j.jpainsymman.2015.12.340
  • Mansor M, Cardosa MS, Vijayan R Prevalence of pain as a symptom in advanced cancer patients. 12th World Congress on Pain; Glasgow, Edinburgh; August 17–22, 2008.
  • Hui D, Bruera E. A personalized approach to assessing and managing pain in patients with cancer. J Clin Oncol. 2014;32:1640–1646. doi:10.1200/JCO.2013.52.2508
  • World Health Organization. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents; 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/279700/9789241550390-eng.pdf?ua=1. Accessed May 29, 2020.
  • World Health Organisation. Adherence to long-term therapies: evidence for action; 2003. Available from: https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf?ua=1. Accessed May 29, 2020.
  • Miaskowski C, Dodd MJ, West C, et al. Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol. 2001;19:4275–4279. doi:10.1200/JCO.2001.19.23.4275
  • Lai YH, Keefe FJ, Sun WZ, et al. Relationship between pain-specific beliefs and adherence to analgesic regimens in Taiwanese cancer patients: a preliminary study. J Pain Symptom Manage. 2002;24:415–423. doi:10.1016/S0885-3924(02)00509-2
  • Janz NK, Becker MH. The health belief model: a decade later. Health Educ Behav. 1984;11:1–47.
  • Ward SE, Goldberg N, Miller-McCauley V, et al. Patient-related barriers to management of cancer pain. Pain. 1993;52:319–324. doi:10.1016/0304-3959(93)90165-L
  • Lucenteforte E, Vagnoli L, Pugi A, et al. A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study. BMC Cancer. 2018;18(1):568. doi:10.1186/s12885-018-4478-3
  • Valeberg BT, Miaskowski C, Hanestad BR, et al. Prevalence rates for and predictors of self-reported adherence of oncology outpatients with analgesic medications. Clin J Pain. 2008;24:627–636. doi:10.1097/AJP.0b013e31816fe020
  • Ripamonti CI, Bandieri E, Roila F. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22:vi69–vi77. doi:10.1093/annonc/mdr390
  • Ministry of Health Malaysia. Clinical practice guidelines: management of cancer pain 1st ed; 2010. Available from: file:///C:/Users/Asus/Downloads/CPG%20Management%20of%20Cancer%20Pain%20(2).pdf. Accessed May 30, 2020.
  • Hassan NB, Hasanah CI, Foong K, et al. Identification of psychosocial factors of noncompliance in hypertensive patients. J Hum Hypertens. 2006;20:23–29. doi:10.1038/sj.jhh.1001930
  • Zahrina AK, Norsa’adah B, Hassan NB, et al. Adherence to capecitabine treatment and contributing factors among cancer patients in Malaysia. Asian Pac J Cancer Prev. 2014;15:9225–9232. doi:10.7314/APJCP.2014.15.21.9225
  • Cleeland C The brief pain inventory user guide. The Brief Pain Inventory; 2009. Available from: https://www.mdanderson.org/documents/Departments-and-Divisions/Symptom-Research/BPI_UserGuide.pdf. Accessed July 25, 2018.
  • Aisyaturridha A, Naing L, Nizar AJ. Validation of the Malay brief pain inventory questionnaire to measure cancer pain. J Pain Symptom Manage. 2006;31:13–21. doi:10.1016/j.jpainsymman.2005.06.011
  • Ahad NA, Yin TS, Othman AR, et al. Sensitivity of normality tests to non-normal data. Sains Malays. 2011;40:637–641.
  • Malaysian National Cancer Registry Report (MNCR) 2012–2016. Available from: https://drive.google.com/file/d/1BuPWrb05N2Jez6sEP8VM5r6JtJtlPN5W/view. Accessed May 28, 2020.
  • Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era. CA Cancer J Clin. 2018;68(3):182–196. doi:10.3322/caac.21453
  • Ministry of Health Malaysia. Malaysian statistics on medicine 2015–2016. Pharmaceutical Services Programme; 2020: 97. Available from: https://www.pharmacy.gov.my/v2/sites/default/files/document-upload/malaysian-statistics-medicines-2015–2016.pdf. Accessed June 1, 2020.
  • Nguyen LMT, Rhondali W, De la Cruz M, et al. Frequency and predictors of patient deviation from prescribed opioids and barriers to opioid pain management in patients with advanced cancer. J Pain Symptom Manage. 2013;45:506–516. doi:10.1016/j.jpainsymman.2012.02.023
  • Liang S-Y, Chen K-P, Tsay S-L, et al. Relationship between belief about analgesics, analgesic adherence and pain experience in Taiwanese cancer outpatients. Asian Pac J Cancer Prev. 2013;14:713–716. doi:10.7314/APJCP.2013.14.2.713
  • Oldenmenger WH, Sillevis Smitt PAE, de Raaf PJ, et al. Adherence to analgesics in oncology outpatients: focus on taking analgesics on time. Pain Pract. 2017;17:616–624. doi:10.1111/papr.12490
  • Kim Y-C, Ahn JS, Calimag MMP, et al. Current practices in cancer pain management in Asia: a survey of patients and physicians across 10 countries. Cancer Med. 2015;4:1196–1204. doi:10.1002/cam4.471
  • Corbett AH, Dana WJ, Fuller MA, et al. Drug Information Handbook (Lexicomp). 25th ed. Ohio: Wolters Kluwer – Medknow Publications; 2016.
  • Gallagher R. Killing the symptom without killing the patient. Can Fam Physician. 2010;56:544–546.
  • Palesh O, Peppone L, Innominato PF, et al. Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer. Nat Sci Sleep. 2012;4:151–162. doi:10.2147/NSS.S18895
  • Bohra MH, Kaushik C, Temple D, et al. Weighing the balance: how analgesics used in chronic pain influence sleep? Br J Pain. 2014;8(3):107‐118. doi:10.1177/2049463714525355
  • Gunnarsdottir S, Donovan HS, Serlin RC, et al. Patient-related barriers to pain management: the Barriers Questionnaire II (BQ-II). Pain. 2002;99:385–396. doi:10.1016/S0304-3959(02)00243-9
  • Kwon JH. Overcoming barriers in cancer pain management. J Clin Oncol. 2014;32:1727–1733. doi:10.1200/JCO.2013.52.4827